Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered public debt offering by Bristol-Myers Squibb Company of $750 million…
Davis Polk advised ContourGlobal Power Holdings S.A., an indirect wholly owned subsidiary of ContourGlobal L.P., in connection with the offering of an additional €100 million aggregate…
Davis Polk advised the sole underwriter on the $679.9 million SEC-registered offering by Cliffs Natural Resources Inc. of 63.25 million of its common shares. The amount sold includes 8.25…
Davis Polk advised IHS Markit Ltd. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 4.75% senior notes due 2025. IHS Markit intends…
Davis Polk advised REV Group, Inc. on its $275 million initial public offering of 12,500,000 shares of common stock. The shares of common stock are listed on the New York Stock Exchange…
Davis Polk advised the sole underwriter in connection with a $201.25 million SEC-registered offering of 3,220,000 shares of common stock of Pinnacle Financial Partners, Inc. Included…
Davis Polk advised Freeport-McMoRan Inc. (the “Company”) in connection with its offer to exchange any and all of the 6.125% senior notes due 2019, 6.50% senior notes due 2020, 6.625% senior…
Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 40,000,000 shares of common stock of Callon Petroleum Company. The shares are…
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $106.3 million follow-on offering of 3,864,000 shares of common stock of…
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…